Related Experiment Videos

Pravastatin versus simvastatin for prevention of contrast-induced nephropathy

Monica A Muñoz1, Pamela R Maxwell, Kay Green

  • 1Department of Pharmacy, University Health System, San Antonio, TX, USA.

Journal of Cardiovascular Pharmacology and Therapeutics
|March 10, 2011
PubMed

Insights

Pravastatin significantly reduced the incidence of contrast-induced nephropathy (CIN) compared to simvastatin in patients undergoing percutaneous coronary intervention (PCI). This finding suggests different statin profiles for kidney protection in interventional cardiology.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Contrast-induced nephropathy (CIN) is a significant complication following percutaneous coronary intervention (PCI), leading to increased morbidity, mortality, and healthcare costs.
  • Statins are hypothesized to offer protective effects against CIN due to their anti-inflammatory and antioxidant properties.
  • Previous research has not directly compared the efficacy of different statins in preventing CIN.

Purpose of the Study:

  • To compare the incidence of CIN in patients receiving simvastatin versus pravastatin undergoing PCI.
  • To evaluate potential differences in statin efficacy for preventing contrast-related kidney injury.

Main Methods:

  • Retrospective, single-center trial involving 261 patients undergoing PCI.
  • Patients were divided into two groups: those receiving simvastatin (n=145) and those receiving pravastatin (n=116).
  • Demographic and clinical data, including risk factors and prophylactic strategies, were analyzed. Incidence of CIN and acute kidney injury (AKI) were primary endpoints.

Main Results:

  • Contrast-induced nephropathy (CIN) occurred in 17.9% of patients on simvastatin versus 8.6% on pravastatin (P < .05).
  • Acute kidney injury (AKI) was observed in 14.5% of the simvastatin group compared to 6.9% in the pravastatin group (P < .05).
  • Multivariate analysis confirmed that the type of statin was an independent predictor for CIN development.

Conclusions:

  • Pravastatin therapy was associated with a significantly lower incidence of CIN compared to simvastatin in patients undergoing PCI.
  • These findings suggest that statin choice may play a role in mitigating CIN risk.
  • Further prospective studies are warranted to confirm these results and elucidate the underlying mechanisms.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...